Literature DB >> 18414510

Confirmation of the genetic association between the U2AF homology motif (UHM) kinase 1 (UHMK1) gene and schizophrenia on chromosome 1q23.3.

Vinay Puri1, Andrew McQuillin, Susmita Datta, Khalid Choudhury, Jonathan Pimm, Srinivasa Thirumalai, Robert Krasucki, Jacob Lawrence, Digby Quested, Nicholas Bass, Caroline Crombie, Gillian Fraser, Nicholas Walker, Helen Moorey, Manaan Kar Ray, Akeem Sule, David Curtis, David St Clair, Hugh Gurling.   

Abstract

UHMK1 has previously been implicated as a susceptibility gene for schizophrenia in the 1q23.3 region by significant evidence of allelic and haplotypic association between schizophrenia and several genetic markers at UHMK1 in a London-based case-control sample. Further fine mapping of the UHMK1 gene locus in the University College London schizophrenia case-control sample was carried out with tagging SNPs. Two additional SNPs were found to be associated with schizophrenia (rs6604863 P = 0.02, rs10753578 P = 0.017). Tests of allelic and haplotypic association were then carried out in a second independent sample from Aberdeen consisting of 858 individuals with schizophrenia and 591 controls. Two of these SNPs also showed association in the Aberdeen sample (rs7513662 P = 0.0087, rs10753578 P = 0.022) and several haplotypes were associated (global permutation P = 0.0004). When the UCL and Aberdeen samples were combined three SNPs (rs7513662 P = 0.0007, rs6427680 P = 0.0252, rs6694863 P = 0.015) and several haplotypes showed association (eg HAP-A, HAP-B, HAP-C permutation P = 0.00005). The finding of allelic association with markers in the UHMK1 gene might help explain why it has not been possible, despite great effort, to satisfactorily confirm previously reported associations between schizophrenia and the genes RGS4 and NOS1AP/CAPON. These genes flank UHMK1 and all three loci are within a 700 kb region showing linkage to schizophrenia. The confirmation of association between UHMK1 and schizophrenia, rather than RGS4 and NOS1AP in the London sample, points to the possibility that previous efforts to accurately fine map a gene in the 1q23.3 region have lacked accuracy or may have suffered from methodological flaws.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18414510     DOI: 10.1038/ejhg.2008.76

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  6 in total

1.  Signaling from the secretory granule to the nucleus: Uhmk1 and PAM.

Authors:  Victor P Francone; Marius F Ifrim; Chitra Rajagopal; Christopher J Leddy; Yanping Wang; John H Carson; Richard E Mains; Betty A Eipper
Journal:  Mol Endocrinol       Date:  2010-06-23

2.  Different requirements of the kinase and UHM domains of KIS for its nuclear localization and binding to splicing factors.

Authors:  Valérie Manceau; Clara L Kielkopf; André Sobel; Alexandre Maucuer
Journal:  J Mol Biol       Date:  2008-06-17       Impact factor: 5.469

3.  The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice.

Authors:  Valérie Manceau; Elisabeth Kremmer; Elizabeth G Nabel; Alexandre Maucuer
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

4.  Association of gene coding variation and resting metabolic rate in a multi-ethnic sample of children and adults.

Authors:  Maciej S Buchowski; Todd L Edwards; Jacklyn N Hellwege; Digna R Velez Edwards; Sari Acra; Kong Chen
Journal:  BMC Obes       Date:  2017-04-05

5.  Analysis of Faecal Microbiota and Small ncRNAs in Autism: Detection of miRNAs and piRNAs with Possible Implications in Host-Gut Microbiota Cross-Talk.

Authors:  Federica Chiappori; Francesca Anna Cupaioli; Arianna Consiglio; Noemi Di Nanni; Ettore Mosca; Vito Flavio Licciulli; Alessandra Mezzelani
Journal:  Nutrients       Date:  2022-03-23       Impact factor: 5.717

6.  Expression of kinase interacting with stathmin (KIS, UHMK1) in human brain and lymphoblasts: Effects of schizophrenia and genotype.

Authors:  Greg C Bristow; Tracy A Lane; Mary Walker; Li Chen; Yoshi Sei; Thomas M Hyde; Joel E Kleinman; Paul J Harrison; Sharon L Eastwood
Journal:  Brain Res       Date:  2009-09-09       Impact factor: 3.252

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.